Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• Shares of Xtant Medical Holdings (NYSEAMERICAN:XTNT) recently traded above their 200-day moving average, indicating possible upward momentum, reaching as high as $0.69.
• The company's market capitalization is currently valued at $93.34 million, with a PE ratio of -7.44 and significant institutional ownership at 69.33%.
• Renaissance Technologies LLC has increased its stake in Xtant Medical by 15%, acquiring an additional 103,825 shares during the fourth quarter.

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT - Get Free Report) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.56 and traded as high as $0.69. Xtant Medical shares last traded at $0.67, with a volume of 657,257 shares changing hands.

Xtant Medical Price Performance

The stock has a market cap of $82.32 million, a PE ratio of -15.79 and a beta of -0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.47 and a quick ratio of 1.03. The firm's 50 day moving average price is $0.63 and its two-hundred day moving average price is $0.57.

Institutional Investors Weigh In On Xtant Medical

Several hedge funds have recently bought and sold shares of the stock. Nantahala Capital Management LLC lifted its holdings in shares of Xtant Medical by 500.3% in the 2nd quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company's stock worth $50,543,000 after acquiring an additional 57,000,000 shares during the last quarter. AWM Investment Company Inc. bought a new stake in shares of Xtant Medical in the 2nd quarter worth approximately $4,875,000. Renaissance Technologies LLC lifted its holdings in shares of Xtant Medical by 15.0% in the 4th quarter. Renaissance Technologies LLC now owns 798,033 shares of the medical device company's stock worth $354,000 after acquiring an additional 103,825 shares during the last quarter. Crescent Grove Advisors LLC lifted its holdings in shares of Xtant Medical by 94.3% in the 2nd quarter. Crescent Grove Advisors LLC now owns 412,024 shares of the medical device company's stock worth $304,000 after acquiring an additional 200,000 shares during the last quarter. Finally, Mink Brook Asset Management LLC lifted its holdings in shares of Xtant Medical by 125.8% in the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company's stock worth $81,000 after acquiring an additional 60,997 shares during the last quarter. 69.33% of the stock is currently owned by institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.